Alex Digesu is a Consultant Obstetrician, Gynaecologist, and Urogynaecology Subspecialist at St. Mary’s Hospital, Imperial College of London, UK. He completed his obstetrics and gynaecology training from the Bari University followed by his Ph.D. degree in oncological, gynaecological, and geriatric surgery from the same university. He completed a 5-year fellowship in urogynaecology at King’s College Hospital, London, UK, and St. Mary’s Hospital followed by a two-year subspecialty training in urogynaecology at Imperial College of London. His area of expertise is urogynecology and neurourology including the assessment and management of patients with lower urinary tract symptoms and pelvic floor dysfunctions. His research studies include management and care of patients presenting a broad range of pelvic floor dysfunction including overactive bladder (OAB) syndrome, urinary incontinence, bladder and urogenital pain, urinary and bowel symptoms, urodynamics (saline, video, and ambulatory urodynamics), 2D, 3D/4D ultrasound imaging as well as MRI imaging of the lower urinary tract and pelvic floor, neurourology, and pelvic organ prolapse. He has been and Investigator in several randomized placebo controlled clinical trials assessing the efficacy and safety of drugs such as tolterodine, solifenacin, darifenacin, oxybutynin, vitamin D3 analogue and beta-3 agonist, and botulinum toxin. He has published extensively on these topics. Since he completed his training, he worked as Obstetrician and Gynaecologist Consultant at several university teaching hospitals as well as district general hospitals in both Italy and Switzerland. He is also an Honorary Senior Lecturer in neurourology at Beata Vergine Hospital, Mendrisio, Switzerland. He is a Member of the editorial board of the International Urogynaecology and Pelvic Floor Dysfunction Journal. In January 2011, he was nominated as the Chairman of the International Urogynecology Association (IUGA) Publication Committee.
Biography Updated on 1 January 2013